[lcus_masonry_article]<\/p>\n
The tenth embodiment in U.S. patent application 19\/540,453 is a diabetes cure discovery method. It uses a probability and synthesis database (e.g., Alchemy Data V2) to identify and validate compounds for diabetes cure. Mechanisms include beta cell regeneration, insulin regeneration, glucose metabolism restoration, cell regeneration, and growth factors. Top discoveries include C-H-O-N-Zn and related complexes with defined synthesis processes and success rates.<\/p>\n
The method is tied to the same Alchemy probability data system that appears as embodiment seven\u2014compound combinations, synthesis methods, discovery reports. So the diabetes work is not a one-off; it is an application of a defined data platform. The patent specifies mechanisms (beta cell, insulin, glucose metabolism, etc.) and calls out C-H-O-N-Zn and related complexes as examples with synthesis and success-rate data.<\/p>\n
The broader disease cure research framework (embodiment thirteen) covers a plurality of diseases (e.g., 300) that typically do not use opioids, organized by category. Diabetes cure discovery fits within that framework and shares the same portfolio filing date and application number. For partners in pharma or therapeutic research, the patent provides a defined method and data linkage, not just a general idea.<\/p>\n
Figure 10 in the specification is a flowchart: compound, mechanisms, pipeline. Application # 19\/540,453, filed February 13, 2026, Confirmation # 1134.<\/p>\n
Source: US Patent Application 19\/540,453, Sections 8.10 and 8.13.<\/em><\/p>\n [\/lcus_masonry_article]<\/p>\n <\/p>\n